ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 63 filers reported holding ADC THERAPEUTICS SA in Q4 2022. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,268,120 | -54.7% | 1,675,959 | -10.9% | 0.06% | -57.7% |
Q4 2022 | $7,219,043 | -20.3% | 1,879,959 | 0.0% | 0.14% | -20.2% |
Q3 2022 | $9,061,000 | -39.4% | 1,879,959 | 0.0% | 0.18% | -44.4% |
Q2 2022 | $14,946,000 | -48.5% | 1,879,959 | -4.8% | 0.32% | -29.7% |
Q1 2022 | $29,013,000 | -27.3% | 1,975,000 | 0.0% | 0.46% | -10.8% |
Q4 2021 | $39,895,000 | +12.0% | 1,975,000 | +50.5% | 0.51% | +8.5% |
Q3 2021 | $35,634,000 | +11.5% | 1,311,990 | 0.0% | 0.47% | +9.6% |
Q2 2021 | $31,948,000 | +43.1% | 1,311,990 | +43.4% | 0.43% | +29.6% |
Q1 2021 | $22,329,000 | -35.1% | 914,739 | -14.9% | 0.33% | -37.3% |
Q4 2020 | $34,411,000 | +79.7% | 1,075,000 | +85.2% | 0.53% | +40.8% |
Q3 2020 | $19,150,000 | +172.8% | 580,483 | +287.0% | 0.38% | +145.1% |
Q2 2020 | $7,021,000 | – | 150,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 1,186,215 | $4,555,066 | 2.69% |
Blue Owl Capital Holdings LP | 733,568 | $2,816,901 | 1.20% |
Redmile Group, LLC | 7,590,849 | $29,148,860 | 1.19% |
AlphaCentric Advisors LLC | 297,500 | $1,142,400 | 1.13% |
Prosight Management, LP | 463,310 | $1,779,110 | 0.97% |
GCM Grosvenor Holdings, LLC | 735,471 | $2,824,209 | 0.72% |
Indie Asset Partners, LLC | 93,839 | $360,342 | 0.40% |
XTX Topco Ltd | 197,635 | $758,918 | 0.16% |
Eventide Asset Management | 1,879,959 | $7,219,043 | 0.14% |
Nantahala Capital Management | 243,290 | $934,234 | 0.06% |